Biocartis Group N.V.
BIOGF · OTC
6/30/2023 | 12/31/2022 | 6/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -5.1% | -99.9% | 138% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -6.3% | -9.1% | 48.2% | 29.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -52.6% | -51.4% | -76.5% | -108.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -105.5% | -117.3% | -113.7% | -148.1% |
| EPS Diluted | -0.34 | -0.58 | -0.5 | -0.62 |
| % Growth | 41.4% | -16% | 19.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |